Literature DB >> 15042626

Response of cyclic AMP by DMSO differentiated HL-60 cells exposed to electric interferential current after prestimulation.

W Sontag1.   

Abstract

The action of interferential current (IFC) upon intracellular content of cyclic adenosine monophosphate (cAMP) after prestimulation with the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) has been investigated. Human promyelocytes (HL-60) differentiated to granulocytes by dimethylsulphoxide (DMSO) have been treated with different concentrations of fMLP. This enhances their cAMP content. The half maximal effective concentration (EC50) was about 4 nM. Exposure to IFC with modulation frequencies of 35 and 125 Hz (5 min, 250 microA/cm2) after prestimulation with various concentrations of fMLP had no enhancing effect at low or high concentrations of fMLP. In contrast, at medium concentrations in the range of about 100 pM fMLP, a significant enhancement of cAMP could be observed. This synergistic effect of fMLP and IFC has been examined in detail by varying the modulation frequency, current density, and exposure time. Enhancement of cAMP content could be observed at certain modulation frequencies and exposure times suggesting a window effect, whereas for the current density in the range measured (8.5 microA/cm2-2.5 mA/cm2) a constant enhancement could be observed. The synergistic effect of fMLP and IFC could only be observed in the treatment sequence of fMLP followed by IFC; an inverse sequence had no effect on the cAMP content. . Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042626     DOI: 10.1002/bem.10183

Source DB:  PubMed          Journal:  Bioelectromagnetics        ISSN: 0197-8462            Impact factor:   2.010


  2 in total

1.  No effect of pulsed electromagnetic fields on PC12 and HL-60 cells.

Authors:  W Sontag; D Kalka
Journal:  Radiat Environ Biophys       Date:  2006-04-20       Impact factor: 1.925

2.  Analgesic and disease modifying effects of interferential current in psoriatic arthritis.

Authors:  U A Walker; M Uhl; S M Weiner; K Warnatz; A Lange-Nolde; H Dertinger; H H Peter; S A Jurenz
Journal:  Rheumatol Int       Date:  2006-01-24       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.